Topical cannabidiol-based treatment for psoriasis: A dual-centre randomized placebo-controlled study
J Eur Acad Dermatol Venereol
.
2022 Sep;36(9):e718-e720.
doi: 10.1111/jdv.18215.
Epub 2022 May 16.
Authors
T Puaratanaarunkon
1
,
S Sittisaksomjai
2
,
N Sivapornpan
2
,
P Pongcharoen
2
,
P Chakkavittumrong
2
,
K Ingkaninan
3
,
P Temkitthawon
3
,
T Promgool
4
,
N Waranuch
4
,
P Asawanonda
1
Affiliations
1
Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
2
Dermatology unit, Department of Internal Medicine, Thammasat University, Bangkok, Thailand.
3
Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
4
Cosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
PMID:
35536599
DOI:
10.1111/jdv.18215
No abstract available
Publication types
Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
MeSH terms
Administration, Topical
Cannabidiol* / therapeutic use
Double-Blind Method
Humans
Psoriasis* / drug therapy
Treatment Outcome
Substances
Cannabidiol
Grants and funding
IRN61W0005/International Research Network for Functional Food Discovery & Development
Thailand Center of Excellence for Life Sciences